Instil Bio, Inc. Income Statement
TIL|1 years of annual SEC 10-K data (FY2021-FY2021)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data. All figures from audited SEC 10-K filings.
Instil Bio, Inc. reported $138,000 in revenue and $38M in net loss for FY2021. Its profit margin was -27346.4% in FY2021.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.30 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2021 |
|---|---|
| Revenue | $138.0K |
| SG&A Expense | $14.4M |
| R&D Expense | $19.4M |
| Operating Income | -$33.6M |
| Income Tax | $151.0K |
| Net Income | -$37.7M |
| EPS (Basic) | -$2.36 |
| EPS (Diluted) | -$2.36 |
| Shares Outstanding | 20.6M |
| Operating Margin | -24379.7% |
| Profit Margin | -27346.4% |